A case report on cefoperazone induced cardiogenic shock - kounis syndrome
1 Senior Clinical Pharmacologist, Manager- Clinical Audit Department, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India - 500003
2 Senior Consultant Haematologist and Medical Oncologist, Department of Oncology, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India- 500003
3 Head , Department of Clinical Audit, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India - 500003
Case Report
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(02), 551–555.
Article DOI: 10.30574/wjbphs.2024.19.2.0544
Publication history:
Received on 12 July 2024; revised on 25 August 2024; accepted on 28 August 2024
Abstract:
Background: Kounis Syndrome is a hypersensitive coronary artery disease caused by the body being exposed to allergens that can be triggered by various medications and environmental factors. The body's defense mechanism launches a surge of chemicals during an anaphylactic reaction that could cause a state of shock, drop in blood pressure and constriction of the breathing passage, which makes breathing difficult.
Case presentation: A 55-year-old woman presented in our department with edema and a growth over her right buccal mucosa. A punch biopsy performed was indicative of squamous cell carcinoma. Considering Chronic Kidney Disease (CKD), consultation with a nephrologist was scheduled and proceeded with the advised recommendations. Following the first injection dose of Cefoperazone and Sulbactum, within 5 minutes, the patient reported chest discomfort and difficulty in breathing. CPR was given according to ACLS protocol. Adrenaline injection was administered and was connected to defibrillator shock.
Conclusion: It is imperative for healthcare providers and pharmacists to recognize that, cephalosporins may result in fatal disorders such as Kounis Syndrome (KS) in order to appropriately prescribe the treatment and take preventative measures.
Keywords:
Kounis syndrome; Cefoperazone; Sulbactum; Cephalospronins; Anaphylaxis
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0